Hydromorphone vs oxycodone
Participant‐reported pain intensity VAS (0‐10, lower score = less pain) · people with moderate to severe cancer pain
1 finding from 1 review
- no estimate extracted4 studies · 462 participantsVery low
The review found no eligible studies for this question.
It is very uncertain whether hydromorphone changes specific adverse events – nausea compared with oxycodone (very low certainty).
It is very uncertain whether hydromorphone changes specific adverse events – vomiting compared with oxycodone (very low certainty).
It is very uncertain whether hydromorphone changes specific adverse events – dizziness compared with oxycodone (very low certainty).
It is very uncertain whether hydromorphone changes specific adverse events – constipation compared with oxycodone (very low certainty).
The review found no eligible studies for this question.